Free Trial

Monopar Therapeutics (MNPR) Institutional Ownership

→ Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad)
Free MNPR Stock Alerts
$0.65
+0.02 (+3.59%)
(As of 12:06 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)

Current
Institutional Ownership
Percentage
1.83%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$55.77K
Number of
Institutional Sellers
(last 12 months)
0
Get MNPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MNPR Institutional Buying and Selling by Quarter

Monopar Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/31/2023Windsor Advisory Group LLC89,974$56K0.1%N/A0.635%
8/13/2021Geode Capital Management LLC28,761$169K0.0%+9.0%0.229%
8/13/2021Vanguard Group Inc.97,462$574K0.0%+116.2%0.775%
5/21/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099%
5/18/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099%
5/17/2021Royal Bank of Canada9,130$57K0.0%N/A0.073%
5/12/2021Northern Trust Corp36,001$223K0.0%-38.8%0.286%
5/12/2021Geode Capital Management LLC26,394$163K0.0%N/A0.210%
5/7/2021BlackRock Inc.11,229$70K0.0%+108.3%0.089%
2/11/2021Northern Trust Corp58,793$360K0.0%-9.2%0.513%
2/5/2021BlackRock Inc.5,391$33K0.0%+99.4%0.047%
(Data available from 1/1/2016 forward)

MNPR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MNPR shares?

During the previous two years, the following institutional investors and hedge funds held shares of Monopar Therapeutics shares: Windsor Advisory Group LLC ($56K).Learn more on MNPR's institutional investors.

What percentage of Monopar Therapeutics stock is owned by institutional investors?

1.83% of Monopar Therapeutics stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings.

Which institutional investors have been buying Monopar Therapeutics stock?

The following institutional investors have purchased Monopar Therapeutics stock in the last 24 months: Windsor Advisory Group LLC ($89.97K).

How much institutional buying is happening at Monopar Therapeutics?

Institutional investors have bought a total of 89,974 shares in the last 24 months. This purchase volume represents approximately $55.77K in transactions.


Related Companies:
This page (NASDAQ:MNPR) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals